▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3420 by analyst upside · 2026-11-13
ICUI
ICU Medical, Inc.
Healthcare · Market Cap $4B · P/E 74.2x
ANALYST PRICE TARGET
+9.6%
implied upside to consensus target
Current Price $177.3
Consensus Target $194.25
Bull Target $210.0
Bear Target $178.0
Analysts Covering 8
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
4
Hold
1
Sell
0
52-Week Low $113.37
52-Week High $192.85
YTD Return +28.0%
FUNDAMENTALS
Market Cap $4B
P/E Ratio (TTM) 74.2x
Forward P/E 18.3x
EPS (TTM) $2.39
PEG Ratio 0.09
Dividend Yield N/A
Revenue (TTM) $2.2B
Profit Margin 2.8%
52-WEEK RANGE
52-Week Low $113.37
52-Week High $192.85
Current Price $177.3
Bear Target $178.0
Bull Target $210.0
● Now $177.3 ● Target $194.25
TRADING DATA
Avg Volume 251K
YTD Return +28.0%
Analyst Count 8
Consensus Buy
Upside to Target +9.6%
Last Updated 2026-11-13

ANALYST SUMMARY

ICU Medical, Inc. (ICUI) is currently trading at $177.3 with a Wall Street consensus price target of $194.25, implying potential upside of 9.6% over the next 12 months. 8 analysts currently cover ICUI, with a consensus rating of Buy - 88% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $210.0, while the most cautious has a target of $178.0.

ICUI operates in the Healthcare sector with a market capitalisation of $4B. The stock is up 28.0% year-to-date and is currently trading near the upper end of its 52-week range of $113.37 – $192.85.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ICUI, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Keybanc - Reiterated
Overweight → Overweight 2026-11-06 Building track record
Piper Sandler - Reiterated
Overweight → Overweight 2026-11-06 14% win rate (7 calls)
Piper Sandler - Reiterated
Overweight → Overweight 2026-08-07 14% win rate (7 calls)
BTIG - Reiterated
Buy → Buy 2026-08-07 38% win rate (8 calls)
Needham - Reiterated
Buy → Buy 2026-08-07 20% win rate (5 calls)
Keybanc - Reiterated
Overweight → Overweight 2026-07-21 Building track record
BTIG ● Initiated
Buy 2026-06-15 38% win rate (8 calls)
Needham ↑ Upgrade
Hold → Buy 2026-05-27 20% win rate (5 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
65
out of 100
Coverage depth
17/30
Consensus clarity
26/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →